VALUE OF 24-HOUR BLOOD PRESSURE MONITORING IN THE DIAGNOSIS OF ARTERIAL HYPERTENSION IN PATIENTSWITH GOUT
https://doi.org/10.14412/1995-4484-2010-1407
Abstract
Objective: To study the detection rate of arterial hypertension in patients with gout by 24-hour blood pressure monitoring (BPM). Results. The study included 93 gouty patients who were arbitrarily divided into 2 groups: 1) 22 (24%) subjects with normal pressure, as measured by the Korotkov method; 2) 71 (76%) patients with elevated blood pressure (BP). All the patients underwent 24-hour BPM. Various 24-hour BPM abnormalities (increases in average daily BP, pulse pressure, load-induced pressure indices, impaired daily BP profile) were found in 100% of the patients in both groups), which is indicative of the presence of latent arterial hypertension in Group 1 patients with gout.
Conclusion. The found 24-hour BPM abnormalities in gouty patients with normal BP, as measured by the Korotkov method, indicate that these patients have latent AH.
Conclusion. The found 24-hour BPM abnormalities in gouty patients with normal BP, as measured by the Korotkov method, indicate that these patients have latent AH.
About the Authors
E I MarkelovaV G Barskova
A E Il'ina
E L Nasonov
E I Markelova
V G Barskova
A E Ilyina
E L Nasonov
References
1. <div><p>Насонова В.А., Барскова В.Г. Ранние диагностика и лечение подагры - научно обоснованное требование улучшения трудового и жизненного прогноза больных. Науч-практ ревматол 2000;l:5-7. 2. Myers A., Epstein F.H., Dodge H.J. et al. The relationship of serum uric acid to risk factors in coronary heart disease. Am J Med 1968;45:520-8.</p><p>Барскова В.Г., Ильиных Е.В., Елисеев М.С. и др. Кардиоваскулярный риск у больных подагрой. Ожирение и метаболизм 2006;3(8):40-4.</p><p>Vazguez-Mellado J., Garsia C.G., Vazguez S.G. et al. Metabolic syndrome and ischemic heart disease in gout. J Clin Rheumatol 2004;10(3):105-9.</p><p>Gutman A.B. Views on the pathgenesis and management of primary gout - 1971. J Bone Joint Surg 1972;54A:357-72.</p><p>Radic M.T., Valkenburg H.A., Davidson R.T. et al. Observations on the natural history of hyperuricemia and gout. I. An eighteen year follow-up of nineteen gouty families. Am J Med 1964;37:862-71.</p><p>Krishnan E., Baker J.F., Furst D.E., Schumacher H.R. Gout and risk of acute myocardial infarction. Arthritis Rheum 2006;54(8):2688-96.</p><p>Weiss T.E., Segaloff A. Gouty Arthritis and Gout. Springfield, III, Thomas, 1959; 7.</p><p>Wyngaarden J.B., Kelley W.N. Gout and hyperuricemia. New York, 1976;512 p.</p><p>Kuzell W.C., Schaffarzick R.W., Naugler W.E. et al. Some observations on 520 gouty patients. J Chronic Dis 1995;2:645-69.</p><p>Vazguez-Mellado J., Garsia C.G., Vazguez S.G. et al. Metabolic syndrome and ischemic heart disease in gout. J Clin Rheumatol 2004;10(3):105-9.</p><p>Johnson R.J., Kang D.-N., Feig D. et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003;41:1183-90.</p><p>Johnson R.J., Rodriguez-Iturbe B., Kang D.H. et al. A unifying pathway for essential hypertension. Am J Hypertens 2005;18:431-40.</p><p>Nakagawa T., Mazzali M., Kang D.H. et al. Hyperuricemia causes glomerular hypertrophy in the rat. Am J Nephrol 2003;23(1):2-7.</p><p>Messerli F.H., Frohlich E.D., Dreslinski G.P. et al. Serum uric acid in essential hypertension: an indicator of renal vascular involvement. Arch Inter Med 1980;93:817-21.</p><p>Puig J.G., Ruilope L.M. Uric acid as a cardiovascular risk factor in arterial hypertension. J Hypertens 1999;17:869-72.</p><p>Чазова И.Е., Ратова Л.Г. Роль суточного мониторирования артериального давления в оценке эффективности антигипертензивной терапии. (Результаты суточного мониторирования артериального давления в программе КЛИП-АККОРД). Consilium medica (прил.) 2007;1:18-26.</p><p>Manchia G. Clinical use of ambulatory blood pressure. Am J Hypertens 1989;2:505-45.</p><p>Горбунов В.М. Некоторые вопросы практического использования суточного мониторирования артериального давления. Клиницист 2008;3:30-40.</p><p>Guidelines for the management of arterial hypertension. J Hypertens 2007;25:1105-87.</p><p>Sega R., Trocino G., Lanzarotti A. et al. Alterations of cardiac structure in patients with isolated office, ambulatory or home hypertension. Data from the general PAMELA population. Circulation 2001;104:1385-92.</p><p>Mancia G., Facchetti R., Bombelli M. et al. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension 2006;47:846-53.</p><p>Fagard R.H., Van Den Broeke C., DeCort P. Prognostic significance of blood pressure measured in the office, at home and during ambulatory monitoring in older patients in general practice. J Hum Hypertens 2005;19:801-7.</p><p>Hansen T.W., Jeppesen J., Rasmussen S., Ibsen H. Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006;19:243-50.</p><p>Ohkubo T., Kikuya M., Metoki H. et al. Prognosis of masked hypertension and white-coat hypertension detected by 24-h ambulatory blood pressure monitoring. J Am Coll Cardiol 2005;46:508-15.</p><p>Bobrie G., Chatellier G., Genes N. et al. Cardiovascular prognosis of «masked hypertension» detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342-9.</p><p>Bjorklund K., Lind L., Zethelius B. et al. Isolated ambulatory hypertension predicts cardiovascular morbidity in elderly men. Circulation 2003;107:1297-302.</p><p>Рогоза A.H., Ошепкова E.B., Цагареишвили Е.В. и др. Современные неинвазивные методы измерения артериального давления для диагностики артериальной гипертонии и оценки эффективности антигипертензивной терапии. М.: Медика, 2007.</p><p>Wallace S.L., Robinson H., Masi A.T. et al. Preliminary criteria for the classification of the acute arthritis of gout. Arthritis Rheum 1977;20:895-900.</p><p>World Health Organization (WHO). Obesity: prevention and management of the global epidemic. Report of the WHO Consultation. World Health Organ Tech. Rep. Ser. 2000;894(i-xii):1-253.</p><p>World Health Organization (WHO). Prevention and management of the global epidemic of obesity. Report of the WHO Consultation on Obesity. Geneva, WHO, 1997.</p><p>Stern J., Hirsch J., Blair S. et al. Weighting the options: criteria for evaluating weight-management programs. The Committee to Develop Criteria for Evaluating the Outcomes of Approaches to Prevent and Treat Obesity. Obes Res 1995;3(6):591-604.</p><p>Рекомендации по профилактике, диагностике и лечению артериальной гипертензии. Российские рекомендации (второй пересмотр). Комитет экспертов Всероссийского научного общества кардиологов. Секция артериальной гипертонии ВНОК. М., 2004. Приложение к журналу «Кардиоваскулярная терапия и профилактика».</p><p>Fagard R.H., Cornelissen V.A. Incidence of cardiovascular events in white-coat, masked and sustained hypertension versus true normotension: a meta-analysis. J Hypertens 2007;25:2193-8.</p><p>Jula A., Puukka P., Karanko H. Multiple clinic and home blood pressure measurements versus ambulatory blood pressure monitoring. Hypertension 1999;34:261-6.</p><p>Martinez M.A., Sancho T., Garcia P. et al. Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage. Blood Press Monit 2006;11:207-13.</p><p>Verdecchia P., Clement D., Fagard R. et al. Blood Pressure Monitoring. Task force III: Target-organ damage, morbidity and mortality. Blood Press Monit 1999;4:303-17.</p><p>Redon J., Gomez-Sanchez M., Baldo E. et al. Microalbuminuria is correlated with left ventricular hypertrophy in male hypertensive patients. J Hypertens 1991;9:148-9.</p><p>Benetos A., Safar M., Rudnichi A. et al. Pulse pressure. A predictor of long-term cardiovascular mortality in a French male population. Hypertension 1997;30:1410-5.</p><p>White W. Analysis of ambulatory blood pressure data in antihypertensive drug trials. J Hypertens 1991;9:27-32.</p><p>White W. Accuracy and analysis of ambulatory blood pressure monitoring data. Clin Cardiolog 1992;15:10-3.</p><p>Fratolla A., Parati G., Cuspidi С. et al. Prognostic value of 24-hour pressure variability. J Hypertens 1993;11:1133-7.</p><p>Parati G., Pompidossi O., Albini E. et al. Relationship of 24-hour blood pressure mean and variability and severity of target-organ damage in hypertension. J Hypertens 1987;5:93-8.</p><p>Willich S.N., Linderer T., Wegascheider K. et al. Increased morning incidence of myocardial infarction in the ISAM study. Absence with prior beta-adrenergic blockade. ISAM study group. Circulation 1989;80:853-8.</p><p>Marler J.R., Price T.R., Clark G.L. et al. Morning increase in onset of ischemic stroke. Stroke 1989;20(4):473-6.</p><p>Schillaci G., Verdecchia P., Benemio G., Porceliati С. Blood pressure rise and ischemic stroke. Lancet 1995;346:1366-7.</p><p>Muller J.E. Circadian variation in cardiovascular events. Am J Hypertens 1999;12(Pt 2):35S-42S.</p><p>Kario К., Pickering Т.G., Umeda Y. et al. Morning surge in blood pressure as a predictor of silent and clinical cerebrovascular disease in elderly hypertensives. A prospective study. Circulation 2003;107:1401-6.</p><p>Somers V., Dyken M., Mark A. et al. Autonomic and hemodynamic responses during sleep in normal and sleep-apneic humans. J Hypertens 1992;10:4.</p><p>O'Brien E., Sheridan J., O'Malley K. Dippers and non-dippers. Lancet 1988;2:327.</p><p>Kario K., Matsua T., Kobayashi H. et al. Nocturnal fall of blood pressure and silent cerebrovascular damage in eldery hypertensive patients: advanced silent cerebrovascular damage in extreme dippers. Hypertension 1996;27:130-5.</p></div><br />
Review
For citations:
Markelova E.I., Barskova V.G., Il'ina A.E., Nasonov E.L., Markelova E.I., Barskova V.G., Ilyina A.E., Nasonov E.L. VALUE OF 24-HOUR BLOOD PRESSURE MONITORING IN THE DIAGNOSIS OF ARTERIAL HYPERTENSION IN PATIENTSWITH GOUT. Rheumatology Science and Practice. 2010;48(1):61-66. (In Russ.) https://doi.org/10.14412/1995-4484-2010-1407
Views:
943
Email this article 